BACKGROUND: Real-world low-risk transcatheter aortic valve replacement (TAVR) outcomes in the United States have not been assessed comprehensively versus pivotal trials, which is a key component of ...
The France Cardiovascular Devices Market is poised to experience substantial growth, anticipated to reach US$ 1.01 billion by 2026, expanding at a robust CAGR of 6.8% from 2020 to 2026. This ...
The Italy cardiovascular devices market is projected to grow by US$ 777 million during 2020-2026, progressing at a robust CAGR of 6.7% over the forecast period.
Patients with severe aortic stenosis had comparable rates of death or disabling stroke, but the lead investigator cautions ...
Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback